Prevention and treatment of interstitial pneumonia and pulmonary fibrosis

摘要

Prevention and treatment of interstitial pneumonia and pulmonary fibrosis which contain compounds having Rho kinase inhibitory activity. In particular, the formula having Rho kinase inhibitory activity is the general formula (I)The compound represented by (+) - trans-4 - (1-aminoethyl) - 1 - (4-pyridyl carbamoyl) cyclohexane, which is a compound expressed by the compound, for example, a prophylactic and therapeutic agent.